Insights
The Bright Side
At Polaris, we light up the media with good news and share inspiring stories. Gaze upon these spotlights:
Our Call to Serve: We’re Veterans Mapping the Biology of Mental Health
https://youtu.be/LoiE2KJtNoc On Veterans Day and always, we honor those who have served. As a veteran-owned business, our founding mission of improving the lives of service members and veterans remains at our roots. As a captain, Purple Heart recipient, 9/11...
Polaris Genomics Advances Mental Health Biomarker Discovery
For decades, psychiatry has struggled with a critical gap: unlike cardiology or oncology, there are no molecular biomarkers to guide diagnosis or treatment. Polaris Genomics was founded to change that, and our mission recently earned global recognition as we...
Conference Posters for Review
Our scientific team is often invited to present posters at a range of academic, pharma, and clinical research conferences focused on neuroscience and mental and brain health. If you have not been able to meet them in person and see our technical information...
Redefining how mental health is understood and treated
I’m Sudhama Swamy, Director of Strategic Partnerships & Business Development. Thank you for taking a few minutes to hear from me. This message is especially relevant if you’re: A pharmaceutical company developing therapies for neuropsychiatric conditions such...
PTSD Rarely Stands Alone; Why Understanding Comorbidity Matters
In the clinical and research worlds, post-traumatic stress disorder (PTSD) is often treated as a singular diagnosis, but the reality is that PTSD rarely occurs in isolation. Comorbid conditions such as alcohol use disorder (AUD), depression, anxiety, and traumatic...
Podcast: Mental Health in the Military and Beyond with Dr. Anne Naclerio
This PTSD Awareness Month, tune into this conversation (on Spotify) on emerging trends, history, lived experience, and research. Thanks to our CMO, Dr Anne, who was recently featured in episode 91 of The Next Iteration Podcast. More options to tune in here:...
Blunt v. Blast & Recurrence Matters: The Future of mTBI Care is Happening Now
In the final installment of our series, Dr. Anne Naclerio sheds light on the future landscape of TBI care, driven by the advancements in biomarker research spearheaded by Polaris Genomics. She also extends a compelling invitation to investors and research partners...
From Battlefield to Breakthrough: Transforming mTBI Research with Biomarkers
In the second part of our discussion with Dr. Anne Naclerio, we explore the burgeoning field of biomarkers and their transformative potential in the diagnosis and treatment of mild traumatic brain injury (mTBI), particularly within military and sports populations....
Mapping Traumatic Brain Injury: Biomarkers & the Future of TBI Care
Resilient yet vulnerable, the human brain is at the heart of everything we do. When it experiences trauma, the consequences can be far-reaching and often invisible to the naked eye. Traumatic brain injury (TBI), ranging from mild concussions to more severe...
Polaris Genomics Featured in Startup Health
Our Story & Recent Successes are Featured in Startup Health Check out our new feature in StartUp Health! Polaris Genomics’ Platform Is Modernizing Mental Health with Molecular Biomarkers; read an excerpt below and the 🧬 full story here. 🧬 Origin Story: A...
Invest in Us
Let’s blaze a brighter future for mental health care togetherWe're glad to connect with you. Now, let's continue to build a partnership! At Polaris Genomics, our team is dedicated to advancing how neuropsychiatric conditions are assessed, diagnosed, and treated by...
Tshaka Cunningham is featured in NAS LABX I was Born Series
Tshaka Cunningham is Featured in LabX's I Was Born Series Our Cofounder & Director of Research and Development Tshaka Cunningham's inspiring story is now featured in the National Academy's powerful new series. An excerpt from their feature is below and...